Cover Image

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer

Gastric/gastroesophageal junction (G/GEJ) cancer represents a significant global health challenge. Radical surgery remains the cornerstone of treatment for resectable G/GEJ cancer. Supported by robust evidence from multiple clinical studies, therapeutic approaches, including adjuvant chemotherapy or...

Full description

Saved in:

Bibliographic Details
Main Authors:	Feizhi Lin (Author), Yongming Chen (Author), Bowen Huang (Author), Shenghang Ruan (Author), Jun Lin (Author), Zewei Chen (Author), Chunyu Huang (Author), Baiwei Zhao (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)

Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
by: Ivy Riano, et al.
Published: (2023)

Photodynamic therapy in combination with immune checkpoint inhibitors plus chemotherapy for first-line treatment in advanced or metastatic gastric or gastroesophageal junction cancer: A phase 2-3 clinical trial protocol
by: Yang Yu, et al.
Published: (2023)

Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
by: Li Chen, et al.
Published: (2022)

Cisplatin Promotes the Efficacy of Immune Checkpoint Inhibitor Therapy by Inducing Ferroptosis and Activating Neutrophils
by: Ziwei Zhou, et al.
Published: (2022)

Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients
by: Zewei Chen, et al.
Published: (2024)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
by: Xi Chen, et al.
Published: (2022)

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
by: Anica Högner, et al.
Published: (2021)

Corrigendum: Controlling nutritional status (CONUT) predicts survival in gastric cancer patients with immune checkpoint inhibitor (PD-1/PD-L1) outcomes
by: Li Chen, et al.
Published: (2022)

Comparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
by: Zhaolun Cai, et al.
Published: (2018)

Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review
by: Qin K, et al.
Published: (2024)

Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials
by: Melissa Bersanelli, et al.
Published: (2022)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
by: Jii Bum Lee, et al.
Published: (2021)

Immune Checkpoint Inhibitors New Insights and Recent Progress
Published: (2023)

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy
by: Lin M, et al.
Published: (2024)

Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis
by: Feng Sheng, et al.
Published: (2023)

The gut microbiota and immune checkpoint inhibitors
by: Audrey Humphries, et al.
Published: (2018)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020)

Immune Checkpoint Inhibitors and Lupus Erythematosus
by: Hans Vitzthum von Eckstaedt, et al.
Published: (2024)

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
by: Hui Zhuan Tan, et al.
Published: (2022)

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
by: Jihyun An, et al.
Published: (2022)

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
by: Lu Gan, et al.
Published: (2022)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024)

Immune Checkpoint in Glioblastoma: Promising and Challenging
by: Jing Huang, et al.
Published: (2017)

Skin Manifestation Induced by Immune Checkpoint Inhibitors
by: Yamamoto T
Published: (2022)

Immune Checkpoint Inhibitors in Melanoma: Review and Update
by: Eugénia Matos Pires, et al.
Published: (2018)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
by: Ji Won Han, et al.
Published: (2021)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
by: Diederick J. van Doorn, et al.
Published: (2020)

Hepatobiliary complications of immune checkpoint inhibitors in cancer
by: Donna Zhuang, et al.
Published: (2024)

Immune checkpoint inhibitor-associated sarcoidosis reaction
by: Parisa Keshtgar, et al.
Published: (2023)

Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
by: Xue-lin Zou, et al.
Published: (2021)

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
by: Shike Lou, et al.
Published: (2024)

Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer
by: Li-Yu Yang, et al.
Published: (2024)

Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
by: Jing Zhao, et al.
Published: (2019)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
by: Yuchun Niu, et al.
Published: (2020)

Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023)

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020)

Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma
by: Giulio Metro, et al.
Published: (2021)